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A method is described to determine the 8-methoxy-
psoralen (8-MOP) concentration in vivo in the skin by 
means of high-performance liquid chromatography 
(HPLC). Skin and blood samples were taken from 80 
rats at specific intervals after oral administration of 
[ 3 H]8-MOP. The pharmacokinetic results obtained for 
the skin levels were compared to the blood levels. In 
a ddition, liquid scintillation counting (LSC) was done 
on all the samples to compare the concentrations of 8-
MOP plus metabolites to the concentrations of 8 -MOP 
alone. 
There was a good correlation between the 8-MOP skin 
and blood levels. The values obtained with LSC were 
higher in function of time than the corresponding values 
obtained by HPLC, which indicates the presence of me-
tabolites in both the skin and the blood. No statistically 
significant difference in the time of peaking was noted 
for the skin and blood levels. The blood levels seem to 
be a good parameter for the 8-MOP skin concentration. 
The most suitable time for the UV A (long-wave ultraviolet 
radiation) exposure seems to be when t he UV A sensitivity of 
t he skin is at a maximum so that t he exposure t ime may be as 
short as possible. However, there can be considerable interin-
dividual differences in maximal UV A sensit ivity [1] as well as 
high interindividual variability in t he 8-methoxypsoralen (8-
MOP) serum levels [2- 12]. In addition, there is a rather high 
intraindividual variabili ty of 8-MOP plasma levels [13]. 
A poor response to PUV A (psoralen plus UV A) t herapy may 
be due to low 8-MOP serum levels at the t ime of the UVA 
irradiation [8]. Nevertheless, good results have been reported 
in some cases with very low serum levels [2]. This might be 
explained by the lack of a positive correlat ion between the 
blood and the skin concentrations. 
In vit ro, t he human epidermis is able to bind and concent rate 
8-MOP without the influence of UV A [14), which could lead to 
high epidermal 8-MOP levels and a prolonged rediffusien t ime 
of t he drug from the skin . This may result in retention of skin 
photosensitivity at even markedly reduced serum levels. Suc-
tion blister fluid studies suggest that the reduction of 8-MOP 
concentration is slower in the skin t han in t he serum [15]. 
Thus, t he 8-MOP plasma concent rat ion does not always seem 
to be a reliable parameter for t he prediction of treatment results 
[16]. A more reliable parameter would be the 8-MOP skin 
concentration. Therefore, we set out to develop a method for 
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8-MOP skin determination and to study the pharmacokinetics 
of 8-MOP in t he skin as compared to t he blood levels. We went 
on to compare t hese results obtained wit h high-performance 
liquid chromatography (HPLC) to the levels obtained by liquid 
scint illation count ing (LSC), measuring not only the 8-MOP 
but also its metaboli tes. 
MATERIALS AND METHODS 
A nimals 
Eighty shaven female Psd:WIST outbred rats weighing about 200 g 
were each orally administered 2 mg of [3H]8-MOP in oil (0.5 ml; 71.20 
11Ci). At regula r intervals (0.5, 1.0, 1.5, 2.0, 2.5, 3.5, 6.0, and 10 h), 10 
rats were decapitated to collect blood and skin samples. After adding 5 
drops of heparin solut ion, one blood sample of 0.5 ml was set aside fo r 
HPLC and two 0.5-ml blood samp les for LSC. T he skin samples were 
taken from t he backs of t he animals, collected in vials, and weighed. 
Two samples were set as ide for HPLC and 6 for LSC. This was done 
for each animal. 
Drug 
An 8-mCi sample of 8- methoxy- [G-3H]psoralen was obtained from 
Amersham International Ltd, Amersham, U.K. It was puri fied with 
HPLC [1 7] on a 23 x 2.5 em column of 15-l'm silicagel part icles in 
methylene chloride. Elution was carried out wit h methylene chloride 
conta ining 0.2% of methanol at 15 mljmin. 
8- MOP Sl~in and Blood Levels 
For each rat, 2 skin samples of about 100 mg each consisting of 
epidermis, dermis, and subcutis were homogenized and extracted with 
a mixture of toluene and n-hexane (60:40) following t he addi t ion of 
100 ng of 5-MO P as t he inte rnal standard. T he organic phases were 
separated by centrifugation and t ransferred into conical tubes. After 
evaporation of t he solvent, t he residues were redissolved in 40 J.Ll of 
methylene chloride and examined by HPLC. A silicagel column (Si60, 
7 11m ) was used. The mobile phase consisted of a mixture of methylene 
chloride: n-hexane: ethanol (100:20:0.1) at 2 ml / min. A UV detector at 
254 nm was used for the detection. The concentrations were calculated 
by means of a calibration graph prepared by adding known amounts of 
8-MOP along wit h 100 ng of in ternal standard to drug-free skin 
samples. 
The other 6 samples from each rat were used to measure tota l 
radioactivity by means of LSC using [3H]n -hexadecane [18] as the 
internal standard. For each rat, 1 blood sample was used for HP LC 
and 2 fo r LSC. T he blood samples for HP LC were extracted according 
to a method we have described elsewhere [19]. 
RESULTS AND DISCUSSION 
The mean values fo r t he 8-MOP skin levels as measured with 
HPLC and LSC are given in Figs 1 and 2. There was no 
statistically significant difference between the different mean 
values 0.5-2.0 h after oral intake, but the differences were 
significant thereafter (p < 0.025 after 2.5 h; p < 0.01 after 3.5 
h; p < 0.005 after 6 h; p < 0.005 after 10 h). The LSC values 
were about 50% higher at 3.5 h t han the HPLC levels. T hese 
differences may obviously be explained by the presence of 
formed metaboli tes not measured by HP LC. 
The 6 skin samples from each rat for LSC were taken from 
diffe rent areas on the back and often showed significant differ-
ences in radioactivity, indicating a diffe rent 8-MOP concentra-
tion depending on the area. This might be because of di ffe rences 
m the fat content of the skin at diffe rent places. Indeed, 8-
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FIG 1. Mean values for the 8-MOP skin and blood levels (ng/g skin 
and ng/ml blood± SD) in function of time in 80 rats (n = 10 per time 
point) as determined by HPLC. 
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FIG 2. Mean values for the 8-MOP skin and blood levels (ng/g skin 
and ng/ml blood± SD) in function of time in 80 rats (n = 10 per time 
point) as determined by LSC. 
MOP is liposoluble and has a low degree of solubility in water. 
This is illustrated by the fact that a fatty meal may enhance 
the resorption of 8-MOP [20]. It has also been demonstrated 
by whole-body autoradiography that UV A irradiation can pro-
duce an increase in the amount of radioactivity in the subcutis, 
particularly in the loose connective tissue layers and in the hair 
follicles [21]. The subcutis accumulation was seen after a high 
8-MOP and radiation dose. No higher radioactivity concentra-
t ions have been found in the subcutis after UV A exposure using 
therapeutic doses of 8-MOP [22]. 
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With skin samples from psoriasis patients but under in vitro 
conditions, a higher label incorporation has been noted in the 
upper layers of the epidermis after UV A irradiation. Indeed, 
parakeratotic cells show a greater degree of photobinding than 
the cells of the basal layer [23]. 
Figures 1 and 2 also show the mean 8-MOP blood levels as a 
function of time as determined by HPLC and by LSC. There 
was no significant difference (p > 0.2) between the different 
mean values 0.5-2.0 h after oral intake for t he 8-MOP as . 
measured by HPLC and by LSC. However, after 2 h the LSC 
levels were significantly higher than the HPLC values for the 
8-MOP alone (p < 0.05 after 2.5 h; p < 0.01 after 3.5 h; p < 
0.0005 after 6 h; p < 0.0005 after 10 h). After 2.5 h, the difference 
was about 25%. In contrast to the skin samples, there was no 
significant difference between the two samples used for LSC 
each time. 
Because 8-MOP is rapidly metabolized, metabolites appear 
in the plasma shortly after oral administration. A reason for 
the relatively long elimination time of the 8-MOP metabolites 
may be a rediffusion of the radioactivity from the tissues into 
the blood [24]. 
Comparison Between 8-MOP Skin and Blood Levels 
On the basis of Figs 1 and 2, there seems to be a good 
correlation between the 8-MOP skin and 'blood levels as deter-
mined by both HPLC and LSC. Only after 1.5 h with LSC and 
after 2 h with HPLC were significant differences noted between 
the blood and skin levels (p < 0.05). The fact that the skin 
levels are then higher than the blood levels might account for 
the retention of skin photosensitivity at even markedly reduced 
serum levels. This concurs with the results of other experiments 
and suggests that the skin may act as a deep compartment 
[25]. 
The difference between LSC and HPLC is higher for the 
skin samples than for the blood samples. This could be attrib-
uted to a difference in pharmacokinetics between the skin and 
the blood for 8-MOP and its metabolites. Another explanation 
could be significant metabolization.in the skin. 
Determination of the 8-MOP blood levels seems to be a good 
parameter for the determination of the skin levels, although 
our experiments do not allow us to conclude that the time of 
peaking is exactly the same for both the skin and the blood. 
However, the similarity of the curves in Figs 1 and 2 suggests 
that there is not a major difference. 
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The Effect of Temperature and Other Factors on Selective 
Microvascular Damage Caused by Pulsed Dye Laser 
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Brief pulses of 577-nm radiation have recently been 
shown to selectively damage superficial cutaneous blood 
vessels, resulting clinically in purpura. There was a 
sharp threshold of exposure dose necessary for causing 
purpura in any given subject, which correlated with 
histologic evidence of extravasation and specific vascu-
lar injury. As a means of study ing mechanisms for such 
damage, heat, cold, pressure, suction, UV radiation, and 
intradermal epinephrine were used to alter human cu-
taneous microvasculature prior to and during 577-nm 
pulsed dye laser exposures. When compared with control 
sites, only cooling of the skin significantly affected the 
exposure dose needed to cause purpura. The magnitude 
of this effect is quantitatively most consistent with in-
travascular microvaporization as the cause of vessel 
rupture and hence purpura. 
In Caucasian skin , superficial cutaneous blood vessels are 
the major sites absorbing 577-nm radiation (green-yellow visi-
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ble light ). When absorbed, t his wavelength therefore generates 
heat specifica lly wit hin superfic ial blood vessels, and if deliv-
ered in a brief, intense pulse can cause selective damage to 
cutaneous microvessels. Accordingly, it has recent ly been 
shown that single, 3 x 10- 7 s (300 ns)-duration pulses of 577-
nm radiation from a pulsed tunable dye laser selectively damage 
Caucasian cutaneous microvessels in vivo at exposure doses of 
2.0 J /cm2 or more [1 ,2]. Histologically, rupture and hemorrhage 
of the superficial vascular plexus were noted with associated 
endothelial and vessel wall necrosis. All vessels to a dept h of 
0.5 mm were affected. A pat tern of acute vasculit is evolved wit h 
fibrin, polymorphonuclear leukocytes, and karyorrhexis in the 
necrotic venular walls. Few or no alterations were apparent at 
t he light microscopic level in dermal fibroblasts, collagen, elas-
t ic tissue, or in t he overlying epidermis, despite significa nt 
vascular damage. The same exposure doses that caused histo-
logically specific effects on blood vessels also caused purpura 
in the exposed skin. This purpura was an ali -or-none response 
occurring within minutes at most and usually immediately after 
exposure. 
Alt hough it is clear t hat purpura results from ext ravasation 
of blood, it is not clear which of several possible damage 
mechanisms may be causing t his superficial hemorrhage. Pos-
sibilit ies include t hermal denaturation, vaporization, and shock 
wave damage [3-5]. At temperatures less t han 100°C, protein 
denaturation, membrane disintegration, and rapid endothelial 
and pericyte cell necrosis may weaken t he vessel wall enough 
to cause hemorrhage and purpura. Alternatively, or in addit ion, 
intravascular vaporization of erythrocytes or plasma may occur, 
